eXoZymes, Inc.
EXOZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $121,028 | $82,767 | $87,444 | $134,101 |
| - Cash | $5,099 | $6,986 | $8,511 | $9,719 |
| + Debt | $1,003 | $1,394 | $1,326 | $1,387 |
| Enterprise Value | $116,933 | $77,176 | $80,259 | $125,769 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$72 | -$72 | -$71 | -$68 |
| % Margin | – | – | – | – |
| EBITDA | -$2,215 | -$2,288 | -$1,880 | -$1,771 |
| % Margin | – | – | – | – |
| Net Income | -$2,287 | -$2,360 | -$1,856 | -$1,836 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.28 | -0.22 | -0.45 |
| % Growth | 3.6% | -27.3% | 51.1% | – |
| Operating Cash Flow | -$1,857 | -$1,538 | -$1,134 | -$5,708 |
| Capital Expenditures | -$13 | -$51 | -$31 | -$210 |
| Free Cash Flow | -$1,870 | -$1,589 | -$1,165 | -$5,918 |